Ginkgo Bioworks Holdings

DNA · NYSE

$9.86−$0.21 (−2.09%)TodayMarket closed ·
Prev close $10.07

Latest news

  • NewsVandana Singh

    Glaukos Reveals Superior Intraocular Pressure Reduction With Novel Eye Therapy

  • NewsVandana Singh

    What's Going on With Ginkgo Bioworks Stock on Friday?

  • NewsAvi Kapoor

    Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

  • Press releaseBusiness Wire

    Ginkgo Bioworks to Provide Autonomous Lab Access to NSF X-Labs Researchers, Contributing Cloud Lab Time and Protein Testing Services to $1.5 Billion Breakthrough Science Program

  • Press releasePRNewswire

    Araceli Biosciences and Ginkgo Bioworks Bring Cellular Imaging at Scale to Nebula's Lab-in-the-Loop

  • NewsAvi Kapoor

    Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday

  • Press releaseBusiness Wire

    Ginkgo Datapoints and Apheris Welcome AbbVie, argenx, Lundbeck, and Takeda as Founding Members of the Antibody Developability Consortium

  • NewsAvi Kapoor

    Everpure, Fervo Energy, Charles River Laboratories And Other Big Stocks Moving Higher On Thursday

  • Press releaseBusiness Wire

    Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data

  • Press releaseBusiness Wire

    Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines

  • Press releasePRNewswire

    Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery

  • Press releasePRNewswire

    The $59B Quiet Shift Reshaping How Patients Access Care

  • Press releasePRNewswire

    Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab

  • Press releasePRNewswire

    Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation

  • NewsChris Katje

    Elon Musk Endorses 'Fundable' Jurassic Park: These De-Extinction Companies Are Already Making It Happen

  • Press releasePRNewswire

    Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure

  • NewsAvi Kapoor

    Flutter Entertainment Posts Downbeat Q4 Results, Joins Zscaler, Elastic And Other Big Stocks Moving Lower In Friday's Pre-Market Session (CORRECTED)

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsVandana Singh

    Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Applied Optoelectronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

  • Press releasePRNewswire

    Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business

  • News

    Earnings Scheduled For February 26, 2026

  • News

    Insights into Ginkgo Bioworks Holdings's Upcoming Earnings

  • Press releasePRNewswire

    Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation

  • Press releasePRNewswire

    Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • Press releasePRNewswire

    Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

  • Press releasePRNewswire

    Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

  • NewsHenry Khederian

    Ginkgo Bioworks (DNA) Shares Rise On New Cancer Screening Approach Plans

  • Press releasePRNewswire

    Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

  • Press releasePRNewswire

    Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

  • Press releasePRNewswire

    Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

  • Press releasePRNewswire

    Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

  • Press releasePRNewswire

    STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

  • Press releasePRNewswire

    Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

  • Press releasePRNewswire

    Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

  • Press releaseBusiness Wire

    Merlin Appoints Ryan Carrithers as Chief Financial Officer, Increasing Public Market Readiness

  • NewsAvi Kapoor

    Hewlett Packard Enterprise, Magnite, GMS And Other Big Stocks Moving Higher On Monday

  • Press releasePRNewswire

    Ginkgo Bioworks Reports First Quarter 2025 Financial Results

  • Press releasePRNewswire

    Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors

  • Press releasePRNewswire

    Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

  • Press releasePRNewswire

    Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care

  • Press releasePRNewswire

    NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture

  • NewsStan Vick

    From Promise to Peril: The Downfall of Ginkgo Bioworks

  • Press releasePRNewswire

    Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals

  • Press releaseBusiness Wire

    Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.